--- title: "Assessing Kirin Holdings Company (TSE:2503) Valuation After New Gut Microbiota Health Collaboration" type: "News" locale: "en" url: "https://longbridge.com/en/news/278199859.md" description: "Kirin Holdings Company (TSE:2503) is gaining attention after its subsidiary Kyowa Kirin partnered with Cowellnex and Metagen to develop gut microbiota health solutions. The company has seen an 8.44% share price increase over 30 days and a 29.85% return over the past year. With a P/E ratio of 14.2x, below industry averages, Kirin appears undervalued compared to its estimated fair value of ¥4,545 per share. However, risks remain if earnings decline or the health initiative falters. Investors are encouraged to explore further opportunities in undervalued stocks." datetime: "2026-03-07T05:58:44.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/278199859.md) - [en](https://longbridge.com/en/news/278199859.md) - [zh-HK](https://longbridge.com/zh-HK/news/278199859.md) --- # Assessing Kirin Holdings Company (TSE:2503) Valuation After New Gut Microbiota Health Collaboration Kirin Holdings Company (TSE:2503) is back in focus after its subsidiary Kyowa Kirin joined Cowellnex and Metagen to research gut microbiota based tests and personalized food recommendation algorithms for Japanese consumers. See our latest analysis for Kirin Holdings Company. The gut health partnership sits alongside a 30 day share price return of 8.44% and a 90 day share price return of 10.62%, while the 1 year total shareholder return of 29.85% points to momentum that has been building rather than fading. If this move into personalized health is on your radar, it could be a good moment to see what else is shaping the future of medicine through our screener of 6 healthcare AI stocks. With the shares up almost 30% over the past year and trading close to a ¥2,644 analyst target yet showing an intrinsic discount of about 43%, you have to ask: is Kirin still undervalued, or is the market already pricing in future growth? ## Price-to-Earnings of 14.2x: Is it justified? On a P/E of 14.2x, Kirin Holdings Company looks cheaper than many peers, even after the recent move that has taken the share price to ¥2,589. P/E compares the current share price with earnings per share and is a quick way to see how much investors are paying for each unit of profit. For a business spanning beer, soft drinks, health science and pharmaceuticals, earnings power often matters more to investors than short term revenue swings. Here, the current 14.2x P/E sits below the peer average of 20.2x and the Asian Beverage industry average of 17.4x. This suggests the market is valuing Kirin’s earnings more conservatively than many comparable names. Against an estimated fair P/E of 23.3x from our regression based fair ratio work, that gap is even wider and points to a level the market could potentially gravitate toward if sentiment on earnings quality and growth were to align with that fair multiple. Explore the SWS fair ratio for Kirin Holdings Company **Result: Price-to-Earnings of 14.2x (UNDERVALUED)** However, the story can shift quickly if earnings soften or if the personalized health push fails to gain traction with consumers and regulators. Find out about the key risks to this Kirin Holdings Company narrative. ## Another View, What Does The Cash Flow Story Say? The earnings based view already looks supportive, but our DCF model goes further and suggests Kirin could be worth around ¥4,545 per share, compared with the current ¥2,589. That implies the shares are trading at a steep discount, so it raises the question of whether the market is being overly cautious. Look into how the SWS DCF model arrives at its fair value. 2503 Discounted Cash Flow as at Mar 2026 Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Kirin Holdings Company for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 24 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity. ## Next Steps If this all feels like a mixed picture, take a moment now to look through the numbers yourself and weigh up the 5 key rewards and 1 important warning sign before you decide what it means for you. ## Looking for more investment ideas? If you are weighing up your next move, do not stop at a single company. Use the tools available to widen your opportunity set. - Target potential mispricings by scanning our list of 24 high quality undervalued stocks that pair earnings power with more modest market expectations. - Strengthen your income playbook by reviewing 20 dividend fortresses that could help anchor a portfolio with regular cash payouts. - Dial down portfolio stress by considering 51 resilient stocks with low risk scores that score well on stability and financial resilience. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### Valuation is complex, but we're here to simplify it. Discover if Kirin Holdings Company might be undervalued or overvalued with our detailed analysis, featuring **fair value estimates, potential risks, dividends, insider trades, and its financial condition.** Access Free Analysis ### Related Stocks - [2503.JP](https://longbridge.com/en/quote/2503.JP.md) - [4151.JP](https://longbridge.com/en/quote/4151.JP.md) ## Related News & Research - [Kirin Holdings Co. (OTCMKTS:KNBWY) Sees Large Decrease in Short Interest](https://longbridge.com/en/news/283006175.md) - [10:00 ETHill's Pet Nutrition Announces 2026 Hill's Global Symposium - "Healthy Skin Starts From Within" - Exploring the Gut-Skin Axis](https://longbridge.com/en/news/286926460.md) - [P-Life Japan Inc. Confirms Scientific Breakthrough in Microbial Bioassimilation of Plastics](https://longbridge.com/en/news/286680259.md) - [08:37 ETRichard Hourigan, Inc. Introduces Special Deals on EnviroBrom Tabs Water Treatment Microbiocide](https://longbridge.com/en/news/286772156.md) - [09:15 ETSeed Health Appoints Anisha Raghavan as First-Ever Chief Marketing Officer to Lead Next Chapter of Brand Growth](https://longbridge.com/en/news/287073326.md)